Carisma Therapeutics Stock Forum

$Carisma Therapeutics (CARM.US)$ considered this gone!

$Carisma Therapeutics (CARM.US)$ 
in progress 😎

$Carisma Therapeutics (CARM.US)$ park sum money here 😎

$Carisma Therapeutics (CARM.US)$
Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
Monday, 9th December at 8:30 am
Resources realigned to focus primarily on in vivo macrophage engineering platform for fibrosis, oncology and autoimmune disease therapies
Development of CT-0525 to be discontinued; workforce reduced by 34%
PHILADELPHIA, Dec. 9, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused ...

$Carisma Therapeutics (CARM.US)$
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
Carisma Therapeutics (NASDAQ: CARM) presented promising preclinical data on engineered macrophages for treating liver fibrosis at AASLD The Liver Meeting® 2024. The research shows that macrophages can be genetically engineered to target specific pathways in liver disease using factors like TIM4, relaxin, an...

$Carisma Therapeutics (CARM.US)$
Will you ever get your ass up? 😭 😭 😭

$Carisma Therapeutics (CARM.US)$
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
Carisma Therapeutics (NASDAQ: CARM) announced positive pre-clinical data for its anti-GPC3 in vivo CAR-M therapy for hepatocellular carcinoma (HCC), developed with Moderna. The therapy demonstrated ability to create CAR-M directly in vivo, reprogramming myeloid cells to target GPC3-expressing cancer cells. Pre-clinical results showed specificity fo...

$Carisma Therapeutics (CARM.US)$
Moderna news / collaboration. 
Yet no movement.  🧐🤔